Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study

Obesity is associated with differences in satiety, gastric emptying (GE), gastric volume, and psychological traits. Exenatide, a short-acting glucagon-like peptide 1 (GLP-1) receptor agonist, is associated with variable weight loss. We compared the effects of exenatide, 5 μg, and placebo SQ, twice d...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Physiol Rep
Main Authors: Acosta, Andres, Camilleri, Michael, Burton, Duane, O’Neill, Jessica, Eckert, Deborah, Carlson, Paula, Zinsmeister, Alan R
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2015
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4632965/
https://ncbi.nlm.nih.gov/pubmed/26542264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.12610
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki